Replay available

Cementos Pacasmayo S.A.A. (CPAC) Q1 2025 Earnings Call

Cementos Pacasmayo S.A.A. (NYSE: CPAC) Q1 2025 earnings conference call, held 2025-04-30. Replay captured from the company's public earnings webcast.

Wed, April 30, 2025 at 9:00 AMendedReplay
Cementos Pacasmayo S.A.A. (CPAC) Q1 2025 Earnings Call

Investor webinar replay

Latest news releases

Companies on this event

Featured Presenters

Claudia Bustamante

Investor Relations Manager

Humberto Nadal

Chief Executive Officer

Manuel Ferreiro

Chief Financial Officer

Marcelo Furlan

Analyst (Itaú)

Replay transcript excerpt

good morning ladies and gentlemen welcome to pacas mayo's first quarter 24 earnings conference call at this time all participants are in a listen only mode and please note that this call is being recorded at the conclusion of our prepared remarks we will conduct a question and answer session i would now like to introduce your host for today's call mrs claudia bustamante investor relations manager mrs bustamante you may begin thank you tim Good morning, everyone. Joining me on the call today is Mr. Humberto Nadal, our Chief Executive Officer, and Mr. Manuel Ferreiro, our Chief Financial Officer. Mr. Nadal will begin our call with an overview of the quarter, focusing primarily on our strategic outlook for the short and medium term. Mr. Ferreiro will then follow with additional commentary on our financial results. We'll then turn the call over to your questions. Please note that this call will include certain forward-looking statements. These statements are related to expectations, beliefs, projections, trends, and other matters that are not historical facts and are therefore subject to risks and uncertainties that might affect future events or results. Descriptions of these risks are set forth in the company's regulatory findings. With that, I'd now like to turn the call over to Mr. Humberto. Thank you, Claudia. Welcome, everyone, to today's conference call, and thank you for joining us today. This quarter, we delivered very solid results in terms of margins, EBITDA, and profitability. Although sales volumes continue to lag behind because of the mindset challenges, we were able to achieve a consolidated EBITDA of $132.8 million, a 10% solid increase year-over-year, as well as a 13.8% increase in net income. By focusing on operational efficiencies related to clinical pr...

More from Cementos Pacasmayo Saa